David Lawrence insider trades: Acorda Therapeutics (ACOR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
54 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 2, 2019 | ACOR | ↓ Sell10b5-1 | 1,176 | $1.60 | $2K | Direct | Dec 4, 2019 (2d) |
| Feb 22, 2019 | ACOR | ↓ Sell | 761 | $13.18 | $10K | Direct | Feb 25, 2019 (3d) |
| Dec 3, 2018 | ACOR | ↓ Sell10b5-1 | 2,493 | $20.55 | $51K | Direct | Dec 6, 2018 (3d) |
| Jun 12, 2018 | ACOR | ↓ Sell10b5-1 | 3,431 | $31.74 | $109K | Direct | Jun 13, 2018 (1d) |
| Jun 8, 2018 | ACOR | ↓ Sell10b5-1 | 25,000 | $28.19 | $705K | Direct | Jun 11, 2018 (3d) |
| Jan 19, 2018 | ACOR | ↓ Sell10b5-1 | 31,000 | $27.58 | $855K | Direct | Jan 22, 2018 (3d) |
| Dec 1, 2017 | ACOR | ↓ Sell10b5-1 | 3,993 | $20.51 | $82K | Direct | Dec 5, 2017 (4d) |
| Oct 9, 2017 | ACOR | ↓ Sell10b5-1 | 250 | $25.40 | $6K | Direct | Oct 11, 2017 (2d) |
| Feb 9, 2017 | ACOR | ↓ Sell10b5-1 | 63,183 | $22.32 | $1.4M | Direct | Feb 13, 2017 (4d) |
| Dec 1, 2016 | ACOR | ↓ Sell10b5-1 | 4,416 | $20.74 | $92K | Direct | Dec 5, 2016 (4d) |
| Oct 7, 2016 | ACOR | ↓ Sell10b5-1 | 250 | $20.82 | $5K | Direct | Oct 11, 2016 (4d) |
| Jun 22, 2016 | ACOR | ↓ Sell10b5-1 | 500 | $25.09 | $13K | Direct | Jun 24, 2016 (2d) |
| Dec 18, 2015 | ACOR | ↓ Sell10b5-1 | 39,026 | $40.63 | $1.6M | Direct | Dec 22, 2015 (4d) |
| Dec 1, 2015 | ACOR | ↓ Sell10b5-1 | 7,167 | $38.08 | $273K | Direct | Dec 3, 2015 (2d) |
| Oct 7, 2015 | ACOR | ↓ Sell10b5-1 | 250 | $29.82 | $7K | Direct | Oct 9, 2015 (2d) |
| Dec 18, 2014 | ACOR | ↓ Sell10b5-1 | 27,109 | $40.11 | $1.1M | Direct | Dec 22, 2014 (4d) |
| Dec 1, 2014 | ACOR | ↓ Sell10b5-1 | 8,898 | $35.60 | $317K | Direct | Dec 3, 2014 (2d) |
| Oct 7, 2014 | ACOR | ↓ Sell10b5-1 | 250 | $33.60 | $8K | Direct | Oct 9, 2014 (2d) |
| Dec 2, 2013 | ACOR | ↓ Sell10b5-1 | 10,836 | $33.51 | $363K | Direct | Dec 4, 2013 (2d) |
| Dec 3, 2012 | ACOR | ↓ Sell10b5-1 | 9,313 | $24.21 | $225K | Direct | Dec 5, 2012 (2d) |
| Dec 1, 2011 | ACOR | ↓ Sell10b5-1 | 9,896 | $22.92 | $227K | Direct | Dec 5, 2011 (4d) |
| Dec 1, 2010 | ACOR | ↓ Sell10b5-1 | 10,905 | $26.54 | $289K | Direct | Dec 3, 2010 (2d) |
| Mar 10, 2010 | ACOR | ↓ Sell | 12,000 | $34.16 | $410K | Direct | Mar 12, 2010 (2d) |
| Feb 2, 2010 | ACOR | ↓ Sell | 5,000 | $30.00 | $150K | Direct | Feb 3, 2010 (1d) |
| Jan 22, 2010 | ACOR | ↓ Sell | 5,000 | $28.00 | $140K | Direct | Jan 26, 2010 (4d) |
| Dec 16, 2009 | ACOR | ↓ Sell | 5,000 | $24.48 | $122K | Direct | Dec 17, 2009 (1d) |
| Dec 1, 2009 | ACOR | ↓ Sell | 7,466 | $24.51 | $183K | Direct | Dec 2, 2009 (1d) |
| Dec 1, 2008 | ACOR | ↓ Sell | 4,134 | $16.02 | $66K | Direct | Dec 3, 2008 (2d) |
| Jun 12, 2008 | ACOR | ↓ Sell | 7,000 | $31.23 | $219K | Direct | Jun 16, 2008 (4d) |
| Jun 4, 2008 | ACOR | ↓ Sell | 21,106 | $29.54 | $623K | Direct | Jun 6, 2008 (2d) |
| Jun 4, 2008 | ACOR | ↓ Sell | 12,000 | $29.82 | $358K | Direct | Jun 6, 2008 (2d) |
| Mar 10, 2008 | ACOR | ↓ Sell | 1,800 | $17.32 | $31K | Direct | Mar 12, 2008 (2d) |
| Jan 23, 2008 | ACOR | ↓ Sell | 1,107 | $22.79 | $25K | Direct | Jan 24, 2008 (1d) |
| Jan 11, 2008 | ACOR | ↓ Sell | 7,000 | $25.00 | $175K | Direct | Jan 11, 2008 (0d) |
| Dec 27, 2007 | ACOR | ↓ Sell | 7,000 | $23.05 | $161K | Direct | Dec 27, 2007 (0d) |
| Dec 21, 2007 | ACOR | ↓ Sell | 1,107 | $20.54 | $23K | Direct | Dec 21, 2007 (0d) |
| Dec 10, 2007 | ACOR | ↓ Sell | 1,800 | $20.40 | $37K | Direct | Dec 11, 2007 (1d) |
| Nov 21, 2007 | ACOR | ↓ Sell | 1,003 | $17.15 | $17K | Direct | Nov 23, 2007 (2d) |
| Oct 23, 2007 | ACOR | ↓ Sell | 1,004 | $20.13 | $20K | Direct | Oct 25, 2007 (2d) |
| Sep 26, 2007 | ACOR | ↓ Sell | 2,008 | $18.78 | $38K | Direct | Sep 27, 2007 (1d) |
| Sep 12, 2007 | ACOR | ↓ Sell | 2,007 | $15.99 | $32K | Direct | Sep 12, 2007 (0d) |
| Jun 15, 2007 | ACOR | ↓ Sell | 2,007 | $18.48 | $37K | Direct | Jun 18, 2007 (3d) |
| May 23, 2007 | ACOR | ↓ Sell | 883 | $24.18 | $21K | Direct | May 24, 2007 (1d) |
| Apr 23, 2007 | ACOR | ↓ Sell | 883 | $24.01 | $21K | Direct | Apr 25, 2007 (2d) |
| Mar 22, 2007 | ACOR | ↓ Sell | 5,941 | $19.63 | $117K | Direct | Mar 27, 2007 (5d) |
| Mar 9, 2007 | ACOR | ↓ Sell | 1,365 | $19.70 | $27K | Direct | Mar 12, 2007 (3d) |
| Feb 23, 2007 | ACOR | ↓ Sell | 5,941 | $23.47 | $139K | Direct | Feb 26, 2007 (3d) |
| Jan 23, 2007 | ACOR | ↓ Sell | 5,941 | $17.55 | $104K | Direct | Jan 24, 2007 (1d) |
| Dec 20, 2006 | ACOR | ↓ Sell | 5,941 | $15.83 | $94K | Direct | Dec 21, 2006 (1d) |
| Dec 11, 2006 | ACOR | ↓ Sell | 900 | $17.03 | $15K | Direct | Dec 12, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Lawrence's insider trades
David Lawrence is Chief, Bus. Ops & PAO at Acorda Therapeutics (ACOR). Since Nov 6, 2006, David has reported no open-market purchases and 54 sales worth $11.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
21 sales (67% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (20 filings), option exercises (15 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACOR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.